| Leslie Harriet Pyle, | |
|
1215 Duff Ave, Ames, IA 50010-5469 | |
| (515) 239-4586 | |
| Not Available |
| Full Name | Leslie Harriet Pyle |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 6 Years |
| Location | 1215 Duff Ave, Ames, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568950970 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 106107 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mary Greeley Medical Center | Ames, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mcfarland Clinic Pc | 1254244239 | 320 |
News Archive
The most recent guidelines for primary prevention recommend aspirin use for individuals ages 40 to 70 years who are at higher risk of a first cardiovascular event, but not for those over 70. Yet, people over 70 are at increasingly higher risks of cardiovascular events than those under 70.
A pair of Scripps Research Institute scientists, one a cancer biologist and the other a chemist, has been awarded $3.85 million from the National Institutes of Health (NIH) to develop a new generation of broad spectrum anti-cancer therapeutics, including breast cancer and lymphoma.
Medyssey Co., Ltd. (Medyssey Spine) today announced a record 112 percent increase in sales in Q4 2010 compared to Q3 2009. Medyssey Spine, privately held, reports year-to-date sales are up 73 percent over 2009, and the company is on pace to achieve its seventh consecutive year of market share growth in the spine market.
The treatment, Xeglyze, was developed by Hatchtech, an Australian pharmaceutical company and will be commercialized by Dr Reddy's Laboratories.
› Verified 1 days ago
| Provider Name | Mcfarland Clinic Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1639135643 PECOS PAC ID: 1254244239 Enrollment ID: O20031106000338 |
News Archive
The most recent guidelines for primary prevention recommend aspirin use for individuals ages 40 to 70 years who are at higher risk of a first cardiovascular event, but not for those over 70. Yet, people over 70 are at increasingly higher risks of cardiovascular events than those under 70.
A pair of Scripps Research Institute scientists, one a cancer biologist and the other a chemist, has been awarded $3.85 million from the National Institutes of Health (NIH) to develop a new generation of broad spectrum anti-cancer therapeutics, including breast cancer and lymphoma.
Medyssey Co., Ltd. (Medyssey Spine) today announced a record 112 percent increase in sales in Q4 2010 compared to Q3 2009. Medyssey Spine, privately held, reports year-to-date sales are up 73 percent over 2009, and the company is on pace to achieve its seventh consecutive year of market share growth in the spine market.
The treatment, Xeglyze, was developed by Hatchtech, an Australian pharmaceutical company and will be commercialized by Dr Reddy's Laboratories.
› Verified 1 days ago
| Provider Name | Broadlawns Medical Center |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1467447508 PECOS PAC ID: 3678466166 Enrollment ID: O20040206000913 |
News Archive
The most recent guidelines for primary prevention recommend aspirin use for individuals ages 40 to 70 years who are at higher risk of a first cardiovascular event, but not for those over 70. Yet, people over 70 are at increasingly higher risks of cardiovascular events than those under 70.
A pair of Scripps Research Institute scientists, one a cancer biologist and the other a chemist, has been awarded $3.85 million from the National Institutes of Health (NIH) to develop a new generation of broad spectrum anti-cancer therapeutics, including breast cancer and lymphoma.
Medyssey Co., Ltd. (Medyssey Spine) today announced a record 112 percent increase in sales in Q4 2010 compared to Q3 2009. Medyssey Spine, privately held, reports year-to-date sales are up 73 percent over 2009, and the company is on pace to achieve its seventh consecutive year of market share growth in the spine market.
The treatment, Xeglyze, was developed by Hatchtech, an Australian pharmaceutical company and will be commercialized by Dr Reddy's Laboratories.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leslie Harriet Pyle, 1215 Duff Ave, Ames, IA 50010-5469 Ph: (515) 239-4400 | Leslie Harriet Pyle, 1215 Duff Ave, Ames, IA 50010-5469 Ph: (515) 239-4586 |
News Archive
The most recent guidelines for primary prevention recommend aspirin use for individuals ages 40 to 70 years who are at higher risk of a first cardiovascular event, but not for those over 70. Yet, people over 70 are at increasingly higher risks of cardiovascular events than those under 70.
A pair of Scripps Research Institute scientists, one a cancer biologist and the other a chemist, has been awarded $3.85 million from the National Institutes of Health (NIH) to develop a new generation of broad spectrum anti-cancer therapeutics, including breast cancer and lymphoma.
Medyssey Co., Ltd. (Medyssey Spine) today announced a record 112 percent increase in sales in Q4 2010 compared to Q3 2009. Medyssey Spine, privately held, reports year-to-date sales are up 73 percent over 2009, and the company is on pace to achieve its seventh consecutive year of market share growth in the spine market.
The treatment, Xeglyze, was developed by Hatchtech, an Australian pharmaceutical company and will be commercialized by Dr Reddy's Laboratories.
› Verified 1 days ago
Dr. Kimberly Jane Harmon, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 217 Duff Ave, Ste 2, Ames, IA 50010 Phone: 515-233-0943 Fax: 515-663-8052 | |
Foot And Ankle Specialists Of Ames, Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 1606 S Duff Ave Ste 500, Ames, IA 50010 Phone: 515-444-2390 | |
Erin N. Nelson, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1606 S Duff Ave Ste 500, Ames, IA 50010 Phone: 515-444-2390 | |
Dr. Mark Vincent Sorrentino, D.P.M Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2222 Philadelphia St., Ames Foot Clinic, Ames, IA 50010 Phone: 515-663-0900 Fax: 515-663-0905 | |
Dr. Charles K. Gilarski, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1215 Duff Ave, Ames, IA 50010 Phone: 515-239-4586 Fax: 515-956-4130 | |
Iowa Foot Care Center Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 217 Duff Ave Ste 2, Ames, IA 50010 Phone: 515-233-0943 Fax: 515-663-8052 |